Previous Close | 7.23 |
Open | 7.68 |
Bid | 9.15 x 100 |
Ask | 9.78 x 100 |
Day's Range | 7.24 - 9.62 |
52 Week Range | 2.76 - 19.20 |
Volume | |
Avg. Volume | 6,998,895 |
Market Cap | 870.144M |
Beta (5Y Monthly) | 1.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -15.67 |
Earnings Date | Jun 20, 2024 - Jun 24, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.63 |
Subscribe to Yahoo Finance Plus to view Fair Value for CGC
Cannabis-related stocks such as Tilray Brands (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB) jumped on news out of Canada and Germany. In Canada, a government group brought together to study the impacts of the legalization legislation recommends the country reduce the excise taxes producers have to pay. Meanwhile, Germany has decriminalized cannabis for personal use. Yahoo Finance's Josh Lipton and Julie Hyman discuss the moves in the video above. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, celebrates the German government's final approval legalizing cannabis, as well as advancing a clear victory for enhanced medical cannabis access.
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced that independent proxy advisory firm Glass Lewis & Co. ("Glass Lewis"), in its report issued on Canopy Growth's special meeting of shareholders scheduled for April 12, 2024, recommended that Canopy Growth shareholders (the "Canopy Shareholders") vote in favour of the previously announced special resolution authorizing an amendment to the Company's articles of incorporation, as amended (the "Ame